SecBot SecBot
DEFA14A ·Filed Oct 6, 2026

PDEX

PRO DEX INC
NEUTRAL
Impact 5/10
Horizonweeks Processed20d 21h ago SEC0001079973-26-001326
Proxy solicitation materials
Actionable Insight • Neutral

Monitor the upcoming shareholder vote for the outcome of the proxy contest between management and activist Nicholas John Swenson. The DEFA14A likely contains management's rebuttal or additional soliciting arguments — review the full document for specific proposals or director nominations being contested.

DirectionNeutral
Confidencemedium
Horizonweeks
Latest settled — T+5d ⚠ clustered
PDEX ▼ -4.75% at T+5d
NEUTRAL call -4.75% · α vs SPY -3.76% · entry $62.80 → $59.82
Next anchor: T+20d in 7d
Latest observation: T+12 -7.37% FF3 residual α
Entry = T+0 close
Oct 6, 2026
via day close
T+1d
-0.94%
call -0.94% · α -0.52%
$62.21
settled 20d ago
T+5d
-4.75%
call -4.75% · α -3.76%
$59.82
settled 14d ago
T+20d
Pending
in 7d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

Pro-Dex, Inc. filed definitive additional proxy soliciting materials (DEFA14A) on October 6, 2026, in connection with its upcoming annual meeting. This filing follows an activist stake disclosure by Nicholas John Swenson (SC 13D/A filed June 26, 2026), indicating an ongoing proxy contest. The DEFA14A likely contains management's supplemental arguments or revised recommendations to shareholders ahead of the vote.

Key Financial Metrics

Vote
director election

Key Facts

  • Filed as DEFA14A (definitive additional proxy materials) on October 6, 2026
  • Filed by the registrant (Pro-Dex management), not a dissident
  • Cross-filing context includes an SC 13D/A filed by Nicholas John Swenson on June 26, 2026, indicating activist stake
  • A definitive proxy statement (DEF 14A) was also filed on October 6, 2026, which this DEFA14A supplements

Financial Impact

No financial figures disclosed in this filing

Risk Factors

  • Activist may seek board seats or strategic changes, creating uncertainty
  • Potential for a contested vote outcome that could shift corporate strategy

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001079973-26-001326
Document: 0001079973-26-001326-index-headers.html0001079973-26-001326
Document: 0001079973-26-001326-index.html0001079973-26-001326
Document: 0001079973-26-001326.txt0001079973-26-001326
7 reports for PDEX
Performance horizon
Filters
Rows
Reports for PDEX — sortable, filterable
TypeNow
Oct 6, 2026
20d ago
DEFA14A
NEUTRAL ★ 5/10
$62.80awaiting T+20—$62.01 (−1.26%)
Oct 6, 2026
20d ago
DEF 14A
NEUTRAL ★ 4/10
$62.80awaiting T+20—$62.01 (−1.26%)
Sep 14, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$66.91 $62.27▼ −6.93%▼ −9.66%$62.01 (−7.32%)
Sep 10, 2026
6w ago
Insider Cluster
NEUTRAL ★ 4/10
$62.81 $62.49▼ −0.50%▼ −2.37%$62.01 (−1.27%)
Aug 28, 2026
8w ago
8-K
NEUTRAL ★ 3/10
$62.10 $70.02▲ +12.75%▲ +12.94%$62.01 (−0.14%)
Jun 17, 2026
18w ago
8-K
NEUTRAL ★ 2/10
$64.37 $59.08▼ −8.22%▼ −8.75%$62.01 (−3.67%)
Apr 30, 2026
25w ago
8-K
MIXED ★ 5/10
$48.36 $66.93▲ +38.40%▲ +33.12%$62.01 (+28.23%)
Showing 7 of 7

US Market Status

Market Open — Closes in 1h 59m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 6, 2026